Alzheimer Disease & Associated Disorders

The Effect of Changing the Amyloid β42 Cut-off of Cerebrospinal Fluid Biomarkers on Alzheimer Disease Diagnosis in a Memory Clinic Population in Norway

The Effect of Changing the Amyloid β42 Cut-off of Cerebrospinal Fluid Biomarkers on Alzheimer Disease Diagnosis in a Memory Clinic Population in Norway

Takk for hjelpen!
Noe gikk galt. Prøv igjen litt senere.
Sender…
Fant du det du lette etter?
0/500 tegn